Upcoming Events See all events >
Latest News See all stories >
New datasets provide insight for cells in lupus and RA disease tissue.
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.
The collaboration between Exagen and GSK will raise awareness of Exagen's AVISE diagnostic and monitoring tests among healthcare professionals around the world.
Advice on recognizing and managing lupus flares from top rheumatologist.
There has been significant progress, not only in awareness, but also in lupus research and advocacy efforts to secure additional research funding for lupus.